Dr Takis Athanasopoulos is Head of Transgene Delivery as part of the Cell & Gene Therapy Research & Development platform at GSK, Stevenage, UK. Before joining GSK, Takis was a Lecturer in Molecular Biotechnology at the University of Wolverhampton (September 2011-2016) and Academic Visitor/Research Consultant for the Gene Therapy Group at Royal Holloway University of London. For 5 years, before joining the Faculty of Science and Engineering at UoW Takis has been a member of the Collaboration for AIDS Vaccine Discovery (CAVD) (www.cavd.org) -an international network of scientists and experts dedicated to designing a variety of novel HIV vaccine candidates and advancing the most promising ones to clinical trials.  Takis has worked previously, as a research staff scientist/PDRA in the School of Biological Sciences at Royal Holloway, University of London (RHUL) (www.rhul.ac.uk). He has also worked on collaborative projects with scientists/clinicians at Royal Free Hospital/UCL and Imperial College London (ICL) and he has been previously funded by the State Scholarship Foundation SF/IKY (Greece), Muscular Dystrophy Campaign (UK), and by the Collaboration for AIDS Vaccine Discovery (CAVD) (www.cavd.org) and the Bill & Melinda Gates Foundation (BMGF).  He has developed critical expertise on various vector systems’ technologies through conducting, collaborating and managing a number of diverse research projects. He holds a BSc in Biochemistry from University of Patras, Greece, and a PhD in Biomedical Sciences from the University of London.   

Areas of Research Interests: Gene Therapy, Virology, Genetic Vaccines & Research Consulting